Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
about
Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsAdolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophreniaEffects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.Asenapine sensitization from adolescence to adulthood and its potential molecular basisLong-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthoodRepeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.Repeated administration of 5-hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity.
P2860
Q26745506-6DB93311-9198-401D-90AB-86B66B2901C6Q30375799-77A55E13-8290-4777-811C-3FCD8EBA164AQ30387361-4C03AD58-085A-4793-B10B-F624540206C2Q30395034-78281E62-9133-4B9B-9DC0-9619DE1C638BQ30401078-2C9A4D33-A188-4D4B-9288-C47A538B0916Q30415567-078EE3D7-C840-46E7-B576-6D0345EBDB5CQ30421478-3BD4A3CE-5B9E-459A-8E2D-EDF51F33FAF9Q34053684-576B35C9-2F8A-4E9D-868E-BDEB4C28919CQ36590407-183E8A5B-1118-407E-9546-FBBCA7AD1434Q37338151-65CB9C94-6026-4004-90DB-B4E106ADC791Q40271784-37817394-A4D1-4108-938F-8026F38A5B05Q50038117-FF48D7EE-65A9-4F7B-9C5D-02A9525805AD
P2860
Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@en
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@nl
type
label
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@en
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@nl
prefLabel
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@en
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@nl
P2093
P2860
P1433
P1476
Repeated asenapine treatment p ...... sts of antipsychotic activity.
@en
P2093
Rongyin Qin
Yingzhu Chen
P2860
P304
P356
10.1016/J.NEUROPHARM.2013.05.031
P577
2013-08-14T00:00:00Z